Emma Hartnett
PhD, BSc
Practice Lead, Risk Modelling and Simulation
Joined RSI in 2006
Country of Residence

Personal Introduction
I am an internationally-recognized expert in risk assessment with experience in diverse risk domains including toxicological, microbiological, and nutritional hazards. I hold a B.Sc. in Microbiology and a Ph.D. in Statistics and Modelling Science. My Ph.D. journey introduced me to the risk assessment field with my thesis focused upon developing a quantitative risk assessment (QRA) model for human infection from campylobacter in chicken. I now specialize in the application of QRA approaches to risk issues related to biological sciences, and risk modelling broadly with a particular emphasis on simulation.
I have developed QRA and decision support tools for wide range of issues, including infectious diseases, microbial and chemical hazards in food and water, exploring the incursion of transboundary animal diseases (for example foot and mouth disease), tools supporting bioterrorism preparedness and response for both microbial and chemical attack agents, and tools to support pandemic health system needs (surge capacity).
I frequently provide expertise to World Health Organization (WHO) and Food and Agricultural Organization (FAO) initiatives in microbial risk assessment, and I was selected to be part of the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment (JEMRA) Roster of Experts (2018-2022). My contributions include as chair of the development of “Guidance of Microbiological Risk Assessment for Food” (posted June 2020 for public comment).
Additional notable activities include providing peer review to The National Academies, Letter Report on the Review of the Food Safety and Inspection Service Proposed Risk-Based Approach to the Application of Public-Health Attribution, and Council of Canadian Academies, Healthy Animals, Healthy Canadians: The Expert Panel on Approaches to Animal Health Risk Assessment, and an invited report to the 35th session of the European Commission for the control of Foot and Mouth Disease.

Dr. Hartnett chairing the FAO CODEX group
Emma Hartnett: Current Focus
Emma currently works on the development of risk-based decision-making processes and tools to support public risk assessment. Current focus includes:
- Working with the Canadian Food Inspection Agency exploring methodologies to support risk-based monitoring of contaminants in food,
- Working with Transport Canada to develop guidelines and methodologies to support risk-based decisions related to public risks from the transportation system.
- Working with the U.S. Food and Drug Administration on continuing expansions and improvements to the FDA-iRISK tool.
Dr. Hartnett also provides training in risk analysis and quantitative risk assessment having previously provided training around the world including Canada, USA, UK, Bahrain, Egypt, China, UAE.
Works and Accomplishments
Dr. Hartnett is an active member of the Society for Risk Analysis (SRA) and was honored with the 2016 Chauncey Starr Distinguished Young Risk Analyst Award by the Society for Risk Analysis for outstanding achievement in science or public policy relating to risk analysis.
Dr. Hartnett is widely published.
Chen, Y., S. B. Dennis, E. Hartnett, G. Paoli, R. Pouillot, T. Ruthman, and M. Wilson. 2013. ‘FDA-iRISK–a comparative risk assessment system for evaluating and ranking food-hazard pairs: case studies on microbial hazards‘, J Food Prot, 76: 376-85.
Guo, C., R. M. Hoekstra, C. M. Schroeder, S. M. Pires, K. L. Ong, E. Hartnett, A. Naugle, J. Harman, P. Bennett, P. Cieslak, E. Scallan, B. Rose, K. G. Holt, B. Kissler, E. Mbandi, R. Roodsari, F. J. Angulo, and D. Cole. 2011. ‘Application of Bayesian techniques to model the burden of human salmonellosis attributable to U.S. food commodities at the point of processing: adaptation of a Danish model‘, Foodborne Pathog Dis, 8: 509-16.
Williams, M. S., E. D. Ebel, N. J. Golden, M. E. Berrang, J. S. Bailey, and E. Hartnett. 2010. ‘Estimating removal rates of bacteria from poultry carcasses using two whole-carcass rinse volumes‘, Int J Food Microbiol, 139: 140-6.
Hartnett, E., G. M. Paoli, and D. W. Schaffner. 2009. ‘Modeling the public health system response to a terrorist event in the food supply‘, Risk Anal, 29: 1506-20.
Newsome, R., N. Tran, G. M. Paoli, L. A. Jaykus, B. Tompkin, M. Miliotis, T. Ruthman, E. Hartnett, F. F. Busta, B. Petersen, F. Shank, J. McEntire, J. Hotchkiss, M. Wagner, and D. W. Schaffner. 2009. ‘Development of a risk-ranking framework to evaluate potential high-threat microorganisms, toxins, and chemicals in food‘, J Food Sci, 74: R39-45.
Gellynck, X., W. Messens, D. Halet, K. Grijspeerdt, E. Hartnett, and J. Viaene. 2008. ‘Economics of reducing Campylobacter at different levels within the Belgian poultry meat chain‘, J Food Prot, 71: 479-85.
Hartnett, E., A. Adkin, M. Seaman, J. Cooper, E. Watson, H. Coburn, T. England, C. Marooney, A. Cox, and M. Wooldridge. 2007. ‘A quantitative assessment of the risks from illegally imported meat contaminated with foot and mouth disease virus to Great Britain‘, Risk Anal, 27: 187-202.
Adkin, A., E. Hartnett, L. Jordan, D. Newell, and H. Davison. 2006. ‘Use of a systematic review to assist the development of Campylobacter control strategies in broilers‘, J Appl Microbiol, 100: 306-15.
Wooldridge, M., E. Hartnett, A. Cox, and M. Seaman. 2006. ‘Quantitative risk assessment case study: smuggled meats as disease vectors‘, Rev Sci Tech, 25: 105-17.
Emma Hartnett: Extra-curricular
Emma enjoys karate and is working towards black belt (shodan). Emma won Gold at the 2020 Douvris Virtual In-house Tournament which included participants from Canada, Ecuador, Guatemala, and Panama. With any extra time, Emma enjoys watching movies, reading, and cooking.
Thank you for your message. Emma Hartnett will be in touch as soon as possible.
-
0%
99% of our added value is our staff.
RSIepidemiologiststoxicologistsmedical doctorsengineersprogrammerssoftware engineerseditorstranslatorscampaignerscommunicatorsperception analystspolicy expertsregulatory advisorschemistsbiologistsclimate expertsurban expertspublic health specialistsmathematicianstrainers
Natalia (Natasha) Shilnikova
At RSI, Dr. Natalia (Natasha) Shilnikova has been working on projects involving toxicology, epidemiology and human health risk assessment, such as development of toxicity profiles for several chemicals on Health Canada’s Domestic Substances List (DSL); a systematic review of potential cancer and reproductive risks of artificial sweeteners for the International…
Full Bio...Daniel Krewski
Dr. Krewski serves as Chief Risk Scientist and CEO of Risk Sciences International. He also holds academic appointments as Professor in the School of Epidemiology and Public Health and Scientific Director of the McLaughlin Centre for Population Health Risk Assessment in the Faculty of Medicine at the University of Ottawa. Dr. Krewski is a Fellow of the Society of Risk Analysis and the American Statistical Association, and a lifetime National Affiliate of the US National Academy of Sciences. In 2013, he received the Distinguished Achievement Award from the Society for Risk Analysis, for excellent performance in the practice of risk analysis. He has contributed to over 900 scientific and technical publications in the field of risk science during the course of his career to date.
Full Bio...Hong Duan
Since joining RSI’s technical team in 2011, Hong has focused on developing risk-based database-driven web projects. Her extensive knowledge and experience, has helped RSI to develop high quality software for multiple clients including the Public Health Agency of Canada, the U.S. Food and Drug Administration, the Food and Agriculture Organization of the United Nations based in Rome, and the World Health Organization based in Geneva.
Full Bio...Todd Ruthman
Todd Ruthman’s current focus is on tools that help regulators visualize and understand the public risk burden within their mandates to help inform risk-based decisions. Mr. Ruthman provides design, management, modelling, coding, and database development expertise for these tools. Mr. Ruthman also manages the RSI development group enhancing previously released tools…
Full Bio...Monique Macdonald
As Office Administrator for RSI, Monique is responsible for managing all functions of the firm’s office environment and administration needs, including liaising with stakeholders, contractors and suppliers, supporting RSI Directors and staff with data management and word processing, maintaining business accounts, licenses, subscriptions, company files and systems. Her duties also include general bookkeeping, sales and marketing support, course and workshop administration and general research support.
Full Bio...Greg Paoli
As RSI’s Principal Risk Scientist and COO, Greg Paoli is currently working with a broad spectrum of clients in the public and private sectors, with the greatest emphasis on the development of new approaches to transform regulatory systems to be more “risk-based” at multiple levels: how senior decision-makers process risk information and make the “tough choices” in regulating health and safety, how an organization can optimize its resources across a diverse mandate to maximize total “portfolio-level” risk reduction, and how to operationalize key resources like the scheduling of inspections when faced with thousands of inspection targets, but not enough resources to inspect all of them.
Full Bio...Nataliya Karyakina
Dr. Nataliya Karyakina has solid knowledge and extensive experience in hazard identification and human health risk assessments of toxic chemicals present in air, water, food and consumer products. Her research focuses on multidisciplinary studies of potential adverse health effects.
Full Bio...Martin LeBlanc
Mr. Martin LeBlanc is responsible for growing RSI’s book of business, supporting all activities to this end. His line is always open to assist clients old and new. He strives to understand and provide a client’s unique need on a project, having done so for many government and private clients across the health, nuclear, power generation, aerospace, manufacturing, transportation and national defence sectors.
Full Bio...Franco Momoli
Dr. Momoli is the acting Practice Lead for Chemical and Product Safety at Risk Sciences International, as well as an adjunct professor in the School of Epidemiology and Public Health at the University of Ottawa.
Full Bio...Mina Maksimovic
Mina joined Risk Sciences International in 2021 as a Project Coordinator. Mina’s focus is helping coordinate projects and implementing project management software to ensure project timelines are met. She also assists with research-based tasks.
Full Bio...Michael G. Tyshenko
Dr. Tyshenko is involved with various health risk issues and is the lead on chemical peer reviews at RSI. He continues international research on infectious disease health policy and evidence-based decision-making for SARS, MERS and COVID-19 with a collaborative working group from China, USA, and the UAE. Other ongoing work in Nepal with the Ministry of Health in collaboration…
Full Bio...Paul Stanish
Paul Stanish joined Risk Sciences International in 2021 as a Risk Analyst. Paul’s current focus is on using emerging tools to modernize client’s understanding risk and streamline and rationalize their data culture.
Full Bio...Anne Wiles
For her work at RSI, Anne has built on her previous experience and academic research through work on communication on nuclear power and nuclear waste disposal; developing communication strategies and messaging on health risk issues; and delivering training on risk communication. She has also applied her familiarity with risk regulation in many projects on government…
Full Bio...Donald Mattison
Dr. Donald Mattison was appointed Chief Medical Officer and Senior Vice President of Risk Sciences International in 2012. Dr. Mattison also serves as Associate Director of the McLaughlin Centre for Population Health Risk Assessment and as Adjunct Professor at the School of Epidemiology and Public Health at the University of Ottawa. He is also Medical Advisor to QuarterWatch: Monitoring FDA MedWatch Reports published by the Institute for Safe Medication Practices in Horsham, Pennsylvania.
Full Bio...Jennifer Go
Jennifer joined RSI in August of 2017 as a Risk Analyst with specialization in epidemiology. She possesses a diverse set of skills that contributes to her flexibility to work on a wide range of scientific projects. In particular, Jennifer has research experience in programming using SAS, manipulating large datasets, constructing statistical models, interpreting quantitative data, …
Full Bio...Cemil ‘Jim’ Alyanak
Now serving as RSI’s Vice-President Communications and Strategic Initiatives, for years Cemil has provided organizations with guidance designed to transmit mission-critical messages. An anti-tobacco campaign is not about promoting a strategy, it’s about saving lives. Get the message wrong and people die. That type of commitment to results is what Cemil brings to Risk Sciences International.
Full Bio...